Patent · US Active

Device for intranasal administration

US8551454B2 · kind B2 · utility

2Cited by

10References

7Claims

0Family size

Assignee

Luitpold Pharmaceuticals, Inc. · US

Inventors

Roger Whiting · Los Altos, US
Ramachandran Thirucote · Atherton, US

Key dates

Filing date	Mar 11, 2010
Grant date	Oct 8, 2013
Priority date	—
Expiry date	May 28, 2031

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB65B31/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are vials and devices containing a ketorolac solution for intranasal administration and a head space comprising no more than about 10% v/v oxygen and which vials and devices are stored in an oxygen-impermeable pouch. Also disclosed are processes for preparing the vials and devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.